Piroska Szabó-Révész - Search Results

Year	Number of Results
2003	1
2005	1
2006	3
2007	5
2008	5
2009	4
2010	3
2011	5
2012	6
2013	5
2014	5
2015	8
2016	11
2017	5
2018	6
2019	9
2020	8
2021	11
2022	3

1

Physico-Chemical, In Vitro and Ex Vivo Characterization of Meloxicam Potassium-Cyclodextrin Nanospheres.

Varga P, Ambrus R, Szabó-Révész P, Kókai D, Burián K, Bella Z, Fenyvesi F, Bartos C. Varga P, et al. Among authors: szabo revesz p. Pharmaceutics. 2021 Nov 6;13(11):1883. doi: 10.3390/pharmaceutics13111883. Pharmaceutics. 2021. PMID: 34834298 Free PMC article.

2

In Vitro Drug Release, Permeability, and Structural Test of Ciprofloxacin-Loaded Nanofibers.

Uhljar LÉ, Kan SY, Radacsi N, Koutsos V, Szabó-Révész P, Ambrus R. Uhljar LÉ, et al. Among authors: szabo revesz p. Pharmaceutics. 2021 Apr 15;13(4):556. doi: 10.3390/pharmaceutics13040556. Pharmaceutics. 2021. PMID: 33921031 Free PMC article.

3

Physico-Chemical and In Vitro Characterization of Chitosan-Based Microspheres Intended for Nasal Administration.

Bartos C, Varga P, Szabó-Révész P, Ambrus R. Bartos C, et al. Among authors: szabo revesz p. Pharmaceutics. 2021 Apr 22;13(5):608. doi: 10.3390/pharmaceutics13050608. Pharmaceutics. 2021. PMID: 33922172 Free PMC article.

4

Development of In Situ Gelling Meloxicam-Human Serum Albumin Nanoparticle Formulation for Nose-to-Brain Application.

Katona G, Sipos B, Budai-Szűcs M, Balogh GT, Veszelka S, Gróf I, Deli MA, Volk B, Szabó-Révész P, Csóka I. Katona G, et al. Among authors: szabo revesz p. Pharmaceutics. 2021 May 1;13(5):646. doi: 10.3390/pharmaceutics13050646. Pharmaceutics. 2021. PMID: 34062873 Free PMC article.

5

Sucrose esters as natural surfactants in drug delivery systems--a mini-review.

Szűts A, Szabó-Révész P. Szűts A, et al. Among authors: szabo revesz p. Int J Pharm. 2012 Aug 20;433(1-2):1-9. doi: 10.1016/j.ijpharm.2012.04.076. Epub 2012 May 7. Int J Pharm. 2012. PMID: 22575672 Review.

6

Fabrication of Submicrometer-Sized Meloxicam Particles Using Femtosecond Laser Ablation in Gas and Liquid Environments.

Nagy E, Andrásik A, Smausz T, Ajtai T, Kun-Szabó F, Kopniczky J, Bozóki Z, Szabó-Révész P, Ambrus R, Hopp B. Nagy E, et al. Among authors: szabo revesz p. Nanomaterials (Basel). 2021 Apr 13;11(4):996. doi: 10.3390/nano11040996. Nanomaterials (Basel). 2021. PMID: 33924560 Free PMC article.

7

Preparation and characterization of lamotrigine containing nanocapsules for nasal administration.

Gieszinger P, Stefania Csaba N, Garcia-Fuentes M, Prasanna M, Gáspár R, Sztojkov-Ivanov A, Ducza E, Márki Á, Janáky T, Kecskeméti G, Katona G, Szabó-Révész P, Ambrus R. Gieszinger P, et al. Among authors: szabo revesz p. Eur J Pharm Biopharm. 2020 Aug;153:177-186. doi: 10.1016/j.ejpb.2020.06.003. Epub 2020 Jun 10. Eur J Pharm Biopharm. 2020. PMID: 32531424

8

The Development of an In Vitro Horizontal Diffusion Cell to Monitor Nasal Powder Penetration Inline.

Gieszinger P, Kiss T, Szabó-Révész P, Ambrus R. Gieszinger P, et al. Among authors: szabo revesz p. Pharmaceutics. 2021 May 28;13(6):809. doi: 10.3390/pharmaceutics13060809. Pharmaceutics. 2021. PMID: 34071664 Free PMC article.

9

Comparison of Modern In Vitro Permeability Methods with the Aim of Investigation Nasal Dosage Forms.

Bartos C, Szabó-Révész P, Horváth T, Varga P, Ambrus R. Bartos C, et al. Among authors: szabo revesz p. Pharmaceutics. 2021 Jun 8;13(6):846. doi: 10.3390/pharmaceutics13060846. Pharmaceutics. 2021. PMID: 34201053 Free PMC article.

10

Formulation and In Vitro and In Silico Characterization of "Nano-in-Micro" Dry Powder Inhalers Containing Meloxicam.

Party P, Bartos C, Farkas Á, Szabó-Révész P, Ambrus R. Party P, et al. Among authors: szabo revesz p. Pharmaceutics. 2021 Feb 3;13(2):211. doi: 10.3390/pharmaceutics13020211. Pharmaceutics. 2021. PMID: 33546452 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results